What is iRhythm Technologies?
Founded in 2006, iRhythm Technologies is a prominent digital healthcare company specializing in the manufacturing of advanced medical devices. Its core offerings revolve around innovative solutions for disease detection, prediction, and prevention, powered by a unique combination of wearable biosensor technology and cloud-based data analytics. The company's proprietary algorithms are designed to analyze millions of heartbeats, converting raw cardiac data into clinically relevant information for healthcare providers. With a global presence spanning North America, Europe, and the Asia-Pacific region, iRhythm Technologies serves both business-to-business and business-to-consumer markets through its digital platforms and mobile applications, solidifying its role as a key player in the digital health and medical technology landscape.
How much funding has iRhythm Technologies raised?
iRhythm Technologies has raised a total of $337.2M across 10 funding rounds:
Other Financing Round
$10M
Series C
$22M
Private Equity
$12.2M
Debt
$3.5M
Series D
$16M
Series E
$17M
Stock Offering
$123M
Stock Offering
$115M
Other Financing Round (2010): $10M supported by Mohr Davidow Ventures, Synergy Life Science Partners, and St. Jude Medical
Series C (2011): $22M featuring Stanford University, New Leaf Venture Partners, Kaiser Permanente Ventures, St. Jude Medical, Mohr Davidow Ventures, and Synergy Life Science Partner
Private Equity (2012): $12.2M backed by New Leaf Venture Partners, Synergy Life Science Partner, Mohr Davidow Ventures, and Kaiser Permanente Ventures
Debt (2012): $3.5M, investors not publicly disclosed
Series D (2013): $16M led by New Leaf Venture Partners, Norwest Venture Partners, Synergy Life Science Partners, and Kaiser Permanente Ventures
Series E (2014): $17M supported by Norwest Venture Partners and Novo A/S
Stock Issuance/Offering (2016): $123.1M, investors not publicly disclosed
Stock Issuance/Offering (2019): $115M, investors not publicly disclosed
Key Investors in iRhythm Technologies
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm focused on early-stage investments in the healthcare sector, particularly in medical devices and digital health. They provide strategic capital and operational expertise to help companies scale and achieve market leadership.
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a strategic venture capital arm focused on investing in healthcare innovation. They aim to advance healthcare solutions that deliver significant value to patients and providers, integrating new technologies into established healthcare systems.
Synergy Life Science Partner
Synergy Life Science Partners is a venture capital firm specializing in early-stage medical device and combination product companies. They offer capital, network access, and technical expertise to foster the growth of innovative healthcare ventures.
What's next for iRhythm Technologies?
With substantial enterprise-level investment, iRhythm Technologies is strategically positioned for accelerated growth and innovation. The company is expected to further enhance its technological capabilities, potentially expanding its diagnostic algorithms and broadening the scope of conditions it can monitor and predict. Future developments may include deeper integration into clinical workflows, increased global market penetration, and the exploration of new therapeutic areas. The ongoing capital will likely fuel research and development, bolster manufacturing capacity, and support strategic partnerships to solidify its leadership in remote cardiac monitoring and digital health solutions.
See full iRhythm Technologies company page
